During the past decade, University Heart Center Hamburg conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 15 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 10 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Heart Center Hamburg" #1 sponsor was "Universitätsklinikum Hamburg-Eppendorf" with 11 trials, followed by "Dr. med. Mahir Karakas" with 5 trials sponsored, "Edwards Lifesciences" with 5 trials sponsored, "Abbott Medical Devices" with 3 trials sponsored and "Boston Scientific Corporation" with 3 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Heart Center Hamburg" #1 collaborator was "Medtronic" with 4 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 3 trials as a collaborator, "German Federal Ministry of Education and Research" with 2 trials as a collaborator, "Labcoat, Ltd." with 2 trials as a collaborator and "Abbott Medical Devices" with 1 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "University Heart Center Hamburg" are "Atrial Fibrillation" (10 trials), "Heart Failure" (7 trials), "Coronary Artery Disease" (6 trials), "Aortic Valve Stenosis" (4 trials) and "Mitral Regurgitation" (4 trials). Many other conditions were trialed in "University Heart Center Hamburg" in a lesser frequency.

Most popular intervention types in "University Heart Center Hamburg" are "Device" (35 trials), "Drug" (13 trials), "Procedure" (9 trials), "Biological" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Aspirin" (2 trials), "Catheter Ablation" (2 trials), "HARPOON Beating Heart Mitral Valve Repair System (MVRS)" (2 trials) and "Ticagrelor" (2 trials). Other intervention names were less common.

The vast majority of trials in "University Heart Center Hamburg" are 71 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University Heart Center Hamburg". undefined are not yet recruiting, 14 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in University Heart Center Hamburg, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in University Heart Center Hamburg, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 29 trials that are defined as “Not Applicable".